UnknownEarly Phase 1

A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

China100 participantsStarted 2021-10-01

Plain-language summary

Ovarian aging (OA) seriously affects the physical and mental health of women. Nowadays, Chinese herbs have huge appeal and potential in treating OA. We have created a new Chinese herbal combination Yijing Keli, whereas its safety and efficacy still need to be validated. Hence, we will perform a population-based, multicenter study to confirm the safety and efficacy of Yijing Keli in therapy of OA. We aim to provide a solid evidence for TCM in therapy of OA.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. The age range of patient is 18-55 years old.
✓. The diagnostic criteria for ovarian aging.
✓. Sign the informed consent form.

Exclusion criteria

✕. Patient is known to be allergic or unsuitable for the Chinese herbal compound.
✕. Women who are pregnant and lactating.
✕. Abnormal uterine bleeding, except ovulation disorders.
✕. Women is taking hormone drugs and has stopped taking them within 3 months;
✕. Women with endometriosis, myadenosis, submucosal fibroids or the size of non- submucosal fibroids is more than 4 cm.
✕. The nature of pelvic mass is unknown.
✕. Women with polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, diabetes, thyroid and adrenal dysfunction and other endocrine diseases affecting ovulation.
✕. Patients with serious primary diseases such as cardiovascular, liver, kidney, lung, biliary, hematopoietic system (Hb\<90g/L) and malignant tumor, and psychiatric patients.

What they're measuring

the recovery rate of ovarian function

Timeframe: 6 months

Trial details

NCT IDNCT06271928

SponsorTongji Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-01

Contact for this trial

jinjin zhang, professor

+8683663078 jinjinzhang@tjh.tjmu.edu.cn

View on ClinicalTrials.gov More Ovarian Aging trials